↓ Skip to main content

GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab: a clinical and translational study

Overview of attention for article published in Journal of Translational Medicine, May 2016
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
2 X users

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
58 Mendeley